Delivery Order SPE2DB22D3011-SPE2DB25FQ2FV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,968.50 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, with no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be performed and delivered from the...
- The Defense Logistics Agency awarded a $9,594.39 delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100 count) with a ceiling value of $2,031.40. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open federal procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,401.40 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100 count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) valued at $5,911.41. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $2,140.26 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lisdexamfetamine 30 mg capsules in quantities of 100 units. The contract carries a firm fixed price structure with no set-aside designation and is scheduled for ultimate completion by August 18, 2025. Performance will be executed from the contractor's facility located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $4,605.78 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the contract from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lisdexamfetamine 20 mg capsules (100-count units) with a contract ceiling value of $2,727.39. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,137.22. This non-set-aside delivery order is scheduled for ultimate completion on August 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lisdexamfetamine 30 mg capsules in quantities of 100 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $2,125.58 and has an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp will perform this contract from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2FVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,503.09 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count packaging). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among qualified vendors meeting federal procurement standards. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs and other federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's status as a critical pharmaceutical distributor within the federal medical supply chain reflects its capability to fulfill diverse federal procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 8/14/25 |